Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report

BACKGROUND: Non-vitamin K antagonist oral anticoagulants, including dabigatran, are currently widely used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Recently, idarucizumab, a monoclonal antibody fragment for immediate reversal of dabigatran-...

Descripción completa

Detalles Bibliográficos
Autores principales: Agosti, Sergio, Casalino, Laura, Rocci, Enrico, Zaccone, Gabriele, Rota, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557536/
https://www.ncbi.nlm.nih.gov/pubmed/28806993
http://dx.doi.org/10.1186/s13256-017-1404-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557536/
https://www.ncbi.nlm.nih.gov/pubmed/28806993
http://dx.doi.org/10.1186/s13256-017-1404-2

Ejemplares similares